1101 related articles for article (PubMed ID: 21569057)
1. Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance.
Silva S; Negri M; Henriques M; Oliveira R; Williams DW; Azeredo J
FEMS Microbiol Rev; 2012 Mar; 36(2):288-305. PubMed ID: 21569057
[TBL] [Abstract][Full Text] [Related]
2. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance.
Krcmery V; Barnes AJ
J Hosp Infect; 2002 Apr; 50(4):243-60. PubMed ID: 12014897
[TBL] [Abstract][Full Text] [Related]
3. Adherence and biofilm formation of non-Candida albicans Candida species.
Silva S; Negri M; Henriques M; Oliveira R; Williams DW; Azeredo J
Trends Microbiol; 2011 May; 19(5):241-7. PubMed ID: 21411325
[TBL] [Abstract][Full Text] [Related]
4. Emergence of non-Candida albicans species: Epidemiology, phylogeny and fluconazole susceptibility profile.
Sadeghi G; Ebrahimi-Rad M; Mousavi SF; Shams-Ghahfarokhi M; Razzaghi-Abyaneh M
J Mycol Med; 2018 Mar; 28(1):51-58. PubMed ID: 29366545
[TBL] [Abstract][Full Text] [Related]
5. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
[TBL] [Abstract][Full Text] [Related]
6. Old and new pathogenic Nakaseomyces species: epidemiology, biology, identification, pathogenicity and antifungal resistance.
Angoulvant A; Guitard J; Hennequin C
FEMS Yeast Res; 2016 Mar; 16(2):fov114. PubMed ID: 26691882
[TBL] [Abstract][Full Text] [Related]
7. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
[TBL] [Abstract][Full Text] [Related]
8. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
[TBL] [Abstract][Full Text] [Related]
9. Candida glabrata fungaemia in intensive care units.
Ruan SY; Lee LN; Jerng JS; Yu CJ; Hsueh PR
Clin Microbiol Infect; 2008 Feb; 14(2):136-40. PubMed ID: 18042196
[TBL] [Abstract][Full Text] [Related]
10. Antifungal susceptibility and phenotypic virulence markers of Candida species isolated from Nepal.
Subramanya SH; Baral BP; Sharan NK; Nayak N; Metok Y; Sathian B; Bairy I; Gokhale S
BMC Res Notes; 2017 Nov; 10(1):543. PubMed ID: 29096684
[TBL] [Abstract][Full Text] [Related]
11. [Neonatal Candida infections and the antifungal susceptibilities of the related Candida species].
Altuncu E; Bilgen H; Cerikçioğlu N; Ilki A; Ulger N; Bakır M; Akman I; Ozek E
Mikrobiyol Bul; 2010 Oct; 44(4):593-603. PubMed ID: 21063972
[TBL] [Abstract][Full Text] [Related]
12. [Investigation of antifungal susceptibilities and some virulence factors of Candida strains isolated from blood cultures and genotyping by RAPD-PCR].
Gültekin B; Eyigör M; Tiryaki Y; Kırdar S; Aydın N
Mikrobiyol Bul; 2011 Apr; 45(2):306-17. PubMed ID: 21644074
[TBL] [Abstract][Full Text] [Related]
13. Insights into Candida tropicalis nosocomial infections and virulence factors.
Negri M; Silva S; Henriques M; Oliveira R
Eur J Clin Microbiol Infect Dis; 2012 Jul; 31(7):1399-412. PubMed ID: 22037823
[TBL] [Abstract][Full Text] [Related]
14. In vitro susceptibility of oral Candida to seven antifungal agents.
Kuriyama T; Williams DW; Bagg J; Coulter WA; Ready D; Lewis MA
Oral Microbiol Immunol; 2005 Dec; 20(6):349-53. PubMed ID: 16238594
[TBL] [Abstract][Full Text] [Related]
15. Epidemiology and antifungal susceptibilities of yeast isolates causing invasive infections across urban Beijing, China.
Guo LN; Xiao M; Cao B; Qu F; Zhan YL; Hu YJ; Wang XR; Liang GW; Gu HT; Qi J; Yuan H; Min R; Wang FY; Liu LJ; Wang HB; Jiang W; Duan XG; Xu WJ; Yu YH; Su JR; Zhang JZ; Nong JQ; Liu SM; Li J; Liu JT; Yue ZG; Yang D; Guo J; Zhao R; Zhang YN; Yang XM; Liu XQ; Hsueh PR; Xu YC
Future Microbiol; 2017 Sep; 12():1075-1086. PubMed ID: 28836465
[TBL] [Abstract][Full Text] [Related]
16. [The changing pattern of Candida infections: different species and increased resistance].
Kullberg BJ; Voss A
Ned Tijdschr Geneeskd; 1996 Jan; 140(3):148-51. PubMed ID: 8618635
[TBL] [Abstract][Full Text] [Related]
17. Study of molecular epidemiology of candidiasis in portugal by PCR fingerprinting of Candida clinical isolates.
Correia A; Sampaio P; Almeida J; Pais C
J Clin Microbiol; 2004 Dec; 42(12):5899-903. PubMed ID: 15583336
[TBL] [Abstract][Full Text] [Related]
18. Biofilms of non-Candida albicans Candida species: quantification, structure and matrix composition.
Silva S; Henriques M; Martins A; Oliveira R; Williams D; Azeredo J
Med Mycol; 2009 Nov; 47(7):681-9. PubMed ID: 19888800
[TBL] [Abstract][Full Text] [Related]
19. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
[TBL] [Abstract][Full Text] [Related]
20. Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.
Bailly S; Maubon D; Fournier P; Pelloux H; Schwebel C; Chapuis C; Foroni L; Cornet M; Timsit JF
J Infect; 2016 Jan; 72(1):103-11. PubMed ID: 26518058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
